Zealand Pharma A/S (ZLDPF)
OTCMKTS · Delayed Price · Currency is USD
63.84
-0.23 (-0.36%)
Feb 11, 2026, 3:17 PM EST
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of $4.51 billion as of February 12, 2026. Its market cap has decreased by -41.74% in one year.
Market Cap
4.51B
Enterprise Value
2.01B
Revenue
1.44B
Ranking
n/a
PE Ratio
4.39
Stock Price
$63.84
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 252.13M to 4.51B, an increase of 1,690.53%. That is a compound annual growth rate of 20.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 4.51B | -12.75% |
| Dec 30, 2025 | 5.17B | -26.44% |
| Dec 30, 2024 | 7.03B | 117.75% |
| Dec 29, 2023 | 3.23B | 116.91% |
| Dec 30, 2022 | 1.49B | 55.96% |
| Dec 30, 2021 | 954.96M | -34.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 411.40M |
| CytoDyn | 305.90M |
| Silence Therapeutics | 204.52M |
| HST Global | 139.70M |
| Vaxart | 137.92M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 72.43M |
| VitaSpring Biomedical | 51.78M |